Medistim ASA
OSE:MEDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangdong PAK Corporation Co Ltd
SZSE:300625
|
CN |
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
CN |
Medistim ASA
EPS (Diluted)
Medistim ASA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
EPS (Diluted)
kr8
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
Lifecare AS
OSE:LIFE
|
EPS (Diluted)
-kr2
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-140%
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
EPS (Diluted)
kr0
|
CAGR 3-Years
58%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's EPS (Diluted)?
EPS (Diluted)
8.7
NOK
Based on the financial report for Dec 31, 2025, Medistim ASA's EPS (Diluted) amounts to 8.7 NOK.
What is Medistim ASA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%
Over the last year, the EPS (Diluted) growth was 54%. The average annual EPS (Diluted) growth rates for Medistim ASA have been 12% over the past three years , 18% over the past five years , and 15% over the past ten years .
